Tue, November 16, 2010
Mon, November 15, 2010
Sun, November 14, 2010
Fri, November 12, 2010
Thu, November 11, 2010
Wed, November 10, 2010
Tue, November 9, 2010
Mon, November 8, 2010
Sun, November 7, 2010
Sat, November 6, 2010
Fri, November 5, 2010
Thu, November 4, 2010
Wed, November 3, 2010
Tue, November 2, 2010
Mon, November 1, 2010
Sat, October 30, 2010
Fri, October 29, 2010
Thu, October 28, 2010

XenoPort to Present at Upcoming Healthcare Conferences

  Copy link into your clipboard //health-fitness.news-articles.net/content/2010/ .. -present-at-upcoming-healthcare-conferences.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

SANTA CLARA, Calif.--([ BUSINESS WIRE ])--XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentations at the Credit Suisse 2010 Healthcare Conference and the 22nd Annual Piper Jaffray Health Care Conference. The live presentations will occur as follows:

Credit Suisse Healthcare Conference 9:30 am EST, November 11, 2010

Piper Jaffray Health Care Conference 1:30 pm EST, November 30, 2010

To access the live presentation via the Web, please go to [ www.XenoPort.com ]. Please connect to the Web site at least 15 minutes prior to the live presentation to ensure adequate time for any software downloads that may be necessary to listen to the Webcast.

A replay of the Webcast can be accessed for a minimum of one week and will be available approximately 24 hours after the live presentation.

About XenoPort

XenoPort, Inc. is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the bodya™s natural nutrient transport mechanisms to improve the therapeutic benefits of existing drugs. XenoPort is developing its lead product candidate in collaboration with Astellas Pharma Inc. and GlaxoSmithKline. XenoPorta™s product candidates are being studied for the potential treatment of restless legs syndrome, neuropathic pain, gastroesophageal reflux disease, spasticity and Parkinsona™s disease.

To learn more about XenoPort, please visit the Web site at [ www.XenoPort.com ].

XenoPort is a registered U.S. trademark.

XNPT2G